Cargando…
The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases
OBJECTIVE: To understand the varieties, evaluation, treatment, and prognosis of severe neurological diseases using the third NCU survey in China. DESIGN: A cross-sectional questionnaire study. The study was completed in three main steps: filling in the questionnaire, sorting out the survey data, and...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990414/ https://www.ncbi.nlm.nih.gov/pubmed/36895910 http://dx.doi.org/10.3389/fneur.2023.1114204 |
_version_ | 1784901936072359936 |
---|---|
author | Su, Yingying Teng, Junfang Tian, Fei Jing, Jing Huang, Huijin Pan, Suyue Jiang, Wen Wang, Furong Zhang, Le Zhang, Yan Zhang, Meng Liu, Liping Cao, Jie Hu, Huaiqiang Li, Wei Liang, Cheng Ma, Liansheng Meng, Xuegang Tian, Linyu Wang, Changqing Wang, Lihua Wang, Yan Wang, Zhenhai Wang, Zhiqiang Xie, Zunchun You, Mingyao Yuan, Jun Zeng, Chaosheng Zeng, Li Zhang, Lei Zhang, Xin Zhang, Yongwei Zhao, Bin Zhou, Saijun Zhou, Zhonghe |
author_facet | Su, Yingying Teng, Junfang Tian, Fei Jing, Jing Huang, Huijin Pan, Suyue Jiang, Wen Wang, Furong Zhang, Le Zhang, Yan Zhang, Meng Liu, Liping Cao, Jie Hu, Huaiqiang Li, Wei Liang, Cheng Ma, Liansheng Meng, Xuegang Tian, Linyu Wang, Changqing Wang, Lihua Wang, Yan Wang, Zhenhai Wang, Zhiqiang Xie, Zunchun You, Mingyao Yuan, Jun Zeng, Chaosheng Zeng, Li Zhang, Lei Zhang, Xin Zhang, Yongwei Zhao, Bin Zhou, Saijun Zhou, Zhonghe |
author_sort | Su, Yingying |
collection | PubMed |
description | OBJECTIVE: To understand the varieties, evaluation, treatment, and prognosis of severe neurological diseases using the third NCU survey in China. DESIGN: A cross-sectional questionnaire study. The study was completed in three main steps: filling in the questionnaire, sorting out the survey data, and analyzing the survey data. RESULTS: Of 206 NCUs, 165 (80%) provided relatively complete information. It was estimated that 96,201 patients with severe neurological diseases were diagnosed and treated throughout the year, with an average fatality rate of 4.1%. The most prevalent severe neurological disease was cerebrovascular disease (55.2%). The most prevalent comorbidity was hypertension (56.7%). The most prevalent complication was hypoproteinemia (24.2%). The most common nosocomial infection was hospital-acquired pneumonia (10.6%). The GCS, APACHE II, EEG, and TCD were the most commonly used (62.4–95.2%). The implementation rate of the five nursing evaluation techniques reached 55.8–90.9%. Routinely raising the head of the bed by 30°, endotracheal intubation and central venous catheterization were the mostprevalent treatment strategies (97.6, 94.5, and 90.3%, respectively). Traditional tracheotomy, invasive mechanical ventilation and nasogastric tube feeding (75.8, 95.8, and 95.8%, respectively) were more common than percutaneous tracheotomy, non-invasive mechanical ventilation and nasogastric tube insertion (57.6, 57.6, and 66.7%, respectively). Body surface hypothermia brain protection technology was more commonly used than intravascular hypothermia technology (67.3 > 6.1%). The rates of minimally invasive hematoma removal and ventricular puncture were only 40.0 and 45.5%, respectively. CONCLUSION: In addition to traditional recognized basic life assessment and support technology, it is necessary to the use of promote specialized technology for neurological diseases, according to the characteristics of critical neurological diseases. |
format | Online Article Text |
id | pubmed-9990414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99904142023-03-08 The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases Su, Yingying Teng, Junfang Tian, Fei Jing, Jing Huang, Huijin Pan, Suyue Jiang, Wen Wang, Furong Zhang, Le Zhang, Yan Zhang, Meng Liu, Liping Cao, Jie Hu, Huaiqiang Li, Wei Liang, Cheng Ma, Liansheng Meng, Xuegang Tian, Linyu Wang, Changqing Wang, Lihua Wang, Yan Wang, Zhenhai Wang, Zhiqiang Xie, Zunchun You, Mingyao Yuan, Jun Zeng, Chaosheng Zeng, Li Zhang, Lei Zhang, Xin Zhang, Yongwei Zhao, Bin Zhou, Saijun Zhou, Zhonghe Front Neurol Neurology OBJECTIVE: To understand the varieties, evaluation, treatment, and prognosis of severe neurological diseases using the third NCU survey in China. DESIGN: A cross-sectional questionnaire study. The study was completed in three main steps: filling in the questionnaire, sorting out the survey data, and analyzing the survey data. RESULTS: Of 206 NCUs, 165 (80%) provided relatively complete information. It was estimated that 96,201 patients with severe neurological diseases were diagnosed and treated throughout the year, with an average fatality rate of 4.1%. The most prevalent severe neurological disease was cerebrovascular disease (55.2%). The most prevalent comorbidity was hypertension (56.7%). The most prevalent complication was hypoproteinemia (24.2%). The most common nosocomial infection was hospital-acquired pneumonia (10.6%). The GCS, APACHE II, EEG, and TCD were the most commonly used (62.4–95.2%). The implementation rate of the five nursing evaluation techniques reached 55.8–90.9%. Routinely raising the head of the bed by 30°, endotracheal intubation and central venous catheterization were the mostprevalent treatment strategies (97.6, 94.5, and 90.3%, respectively). Traditional tracheotomy, invasive mechanical ventilation and nasogastric tube feeding (75.8, 95.8, and 95.8%, respectively) were more common than percutaneous tracheotomy, non-invasive mechanical ventilation and nasogastric tube insertion (57.6, 57.6, and 66.7%, respectively). Body surface hypothermia brain protection technology was more commonly used than intravascular hypothermia technology (67.3 > 6.1%). The rates of minimally invasive hematoma removal and ventricular puncture were only 40.0 and 45.5%, respectively. CONCLUSION: In addition to traditional recognized basic life assessment and support technology, it is necessary to the use of promote specialized technology for neurological diseases, according to the characteristics of critical neurological diseases. Frontiers Media S.A. 2023-02-21 /pmc/articles/PMC9990414/ /pubmed/36895910 http://dx.doi.org/10.3389/fneur.2023.1114204 Text en Copyright © 2023 Su, Teng, Tian, Jing, Huang, Pan, Jiang, Wang, Zhang, Zhang, Zhang, Liu, Cao, Hu, Li, Liang, Ma, Meng, Tian, Wang, Wang, Wang, Wang, Wang, Xie, You, Yuan, Zeng, Zeng, Zhang, Zhang, Zhang, Zhao, Zhou and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Su, Yingying Teng, Junfang Tian, Fei Jing, Jing Huang, Huijin Pan, Suyue Jiang, Wen Wang, Furong Zhang, Le Zhang, Yan Zhang, Meng Liu, Liping Cao, Jie Hu, Huaiqiang Li, Wei Liang, Cheng Ma, Liansheng Meng, Xuegang Tian, Linyu Wang, Changqing Wang, Lihua Wang, Yan Wang, Zhenhai Wang, Zhiqiang Xie, Zunchun You, Mingyao Yuan, Jun Zeng, Chaosheng Zeng, Li Zhang, Lei Zhang, Xin Zhang, Yongwei Zhao, Bin Zhou, Saijun Zhou, Zhonghe The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
title | The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
title_full | The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
title_fullStr | The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
title_full_unstemmed | The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
title_short | The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases |
title_sort | development of neurocritical care in china from the perspective of evaluation and treatment of critical neurological diseases |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990414/ https://www.ncbi.nlm.nih.gov/pubmed/36895910 http://dx.doi.org/10.3389/fneur.2023.1114204 |
work_keys_str_mv | AT suyingying thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT tengjunfang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT tianfei thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT jingjing thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT huanghuijin thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT pansuyue thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT jiangwen thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wangfurong thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhangle thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhangyan thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhangmeng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT liuliping thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT caojie thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT huhuaiqiang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT liwei thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT liangcheng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT maliansheng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT mengxuegang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT tianlinyu thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wangchangqing thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wanglihua thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wangyan thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wangzhenhai thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wangzhiqiang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT xiezunchun thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT youmingyao thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT yuanjun thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zengchaosheng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zengli thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhanglei thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhangxin thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhangyongwei thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhaobin thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhousaijun thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhouzhonghe thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT suyingying developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT tengjunfang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT tianfei developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT jingjing developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT huanghuijin developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT pansuyue developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT jiangwen developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wangfurong developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhangle developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhangyan developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhangmeng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT liuliping developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT caojie developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT huhuaiqiang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT liwei developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT liangcheng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT maliansheng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT mengxuegang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT tianlinyu developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wangchangqing developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wanglihua developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wangyan developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wangzhenhai developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT wangzhiqiang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT xiezunchun developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT youmingyao developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT yuanjun developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zengchaosheng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zengli developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhanglei developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhangxin developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhangyongwei developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhaobin developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhousaijun developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases AT zhouzhonghe developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases |